Zug, Swiss And Scramble,, July 11, 2025 / Prnewswire / – Bio Investments Group AG (BIG), a global platform for global transfer of health technology and the international Vaccine Institute (IVI), an international organization dedicated to the progress of the discovery, development and delivery of vaccines, announced today the signing of an understanding memorandum (Mou) to establish a strategic collaboration to accelerate acceleration Africa and the Middle East.
This partnership highlights a shared vision to improve global health security by promoting self -sufficiency self -sufficiency on emerging markets, aligning Big’s execution and investment capacities with IVI technical advice and IVI regulatory research and expertise.
“This memorandum of understanding marks a pivotal moment in our mission to locate science-life capacities where they are most necessary,” said Sam Machour, CEO and president of the organic investments group. “By associating with IVI, an institution on a global scale, we combine our investments and our technical pharmaceutical capacities in advanced infrastructure and their transfer of technology with their expert in deep scientific and public health. Our joint efforts will accelerate the pace of self -sufficiency, not only large -scale vaccines through vaccinations and creations of African work.
The main areas of cooperation under the memorandum of understanding include:
- Local manufacturing and technology transfer: IVI will provide technical expertise and regulatory support to facilitate the prequalification of locally manufactured products, while Big will direct the development of infrastructure and the execution of technology transfer, guaranteeing efficient and high -quality local vaccine production in Africa.
- Clinical development and data generation: IVI will coordinate clinical trials, efficiency studies and safety research in Africa To generate the basis of evidence necessary for the introduction of vaccines and the adoption of the public sector, with major strategies of industrial engagement and market access.
- Capacity building and vaccination autonomy: IVI will offer training programs and technical assistance to develop local expertise, by supporting public-private partnerships for the vaccine self-affair. Big will invest in physical infrastructure, such as centers of excellence, and will collaborate on vaccine safety strategies, aimed at building sustainable local workforce and establishing regional leadership in the manufacture of vaccines.
This collaboration should contribute significantly African Presentation of public health by promoting a robust and resilient vaccine ecosystem, reducing dependence on imports and strengthening regional preparation for future health challenges.
About Bio Investments Group (Big): Bio Investments Group AG is an industrial platform for health care registered in Switzerland dedicated to the acceleration of the location of science-life capacities, in particular vaccines, biologicals, diagnostics and services of the cold chain, on emerging markets. With operational hubs in Zug, Hong Kong,, DubaiAnd RiyadhBIG focuses on the transfer of technology, the construction of infrastructure and the promotion of local expertise to achieve real manufacturing sovereignty.
About the International Institute of Vaccines (IVI): The International Vaccine Institute (IVI) is an international organization dedicated to advancing the discovery, development and delivery of vaccines, in particular for vulnerable communities. Thanks to research, partnerships and innovation, IVI improves global health, strengthens pandemic preparation and ensures fair access to vital vaccines in the world.
Media contact:
www.bioinvgroup.com
Show the original content:https://www.prnewswire.com/apac/news-releases/bio-investiments-group-big-and-innational-vaccine-institute-ivi-forge-startnership-accelerate-vaccine-elliance-in-frica-middle-middle-middle-middle-middle-middle
Bio Investments Group Source
